SOURCE: Bio-Quant, Inc.
BIO-QUANT, INC. RELOCATES HEADQUARTERS.
New Site Features State-of-the-Art Drug Development and Contract Research Facility and Corporate Offices.
SAN DIEGO, CALIFORNIA, April 23, 2007
--Bio-Quant, Inc., Drug Development and Contract Research Company announced today that it has relocated its headquarters to new purpose-built and expanded facility in San Diego, California.
The new location features a state-of-the-art manufacturing facility that can accommodate the growing demand for Bio-Quant’s Contract Research. It will also house the company’s corporate offices.
"Our new facility provides us with the means to continue to expand to meet our growing customer base, as well as, accommodate our internal drug development," said Bassam B. Damaj, Ph.D., CEO and CSO of Bio-Quant. "Since 2001 the company has continued to grow, and the tremendous growth that we’ve experienced over the past three years, has generated the need to expand our facilities."
About Bio-Quant, Inc.
Bio-Quant, Inc. is a profitable revenue-generating biotechnology company located in San Diego, California. It has focused its efforts on developing our biopharmaceutical drug candidates in the areas of oncology, microbial and immunological diseases as well as providing contract pre-clinical development and drug discovery services to other bio-pharmaceutical companies. Bio-Quant has several compounds in various stages of pre-clinical development. Bio-Quant applies its expertise in immunology and oncology in developing biopharmaceuticals to fight chronic diseases, such as brain and colon cancers, lymphoma, leukemia, vitiligo and cirrhosis.
More information is available at
www.bio-quant.com.